In conclusion, our data demonstrated that sunitinib-resistant ccRCC cell lines aberrantly expressed PD-L1 and presented an increased activation of the Axl and MAPK pathways, and a metabolic shift toward oxidative phosphorylation and glutamine metabolism. This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.